【摘 要】目的：探究实施冠状动脉支架植入术治疗患者中塞来昔布短期治疗对其hsCRP的影响情况。方法：随机抽取我院2017年6月-2018年6月实施冠状动脉支架植入术治疗的患者130例作为研究对象，按照用药不同分两组，对照组在常规治疗基础上增加安慰剂辅助治疗，实验组在常规治疗基础上增加塞来昔布治疗。结果：各组患者手术完成即刻hsCRP检查结果均高于本组手术前，各组患者手术完成后3天hsCRP与本组手术完成即刻相比有升高，实验组患者手术后3天hsCRP低于对照组，以上各组差异均有统计学意义(P<0.05)，结论：塞来昔布在治疗中的应用能够有效缓解术后hsCRP升高情况，对于术后康复效果显著，但考虑其可能会对血流动力学造成一定影响，因此，针对其在临床治疗中的应用还需要进行进一步的研究和分析。

    【关键词】冠状动脉支架植入术；塞来昔布；hsCRP血液生化检验

    Abstract：Objective To investigate the effect of short-term treatment with celecoxib on hsCRP in patients undergoing coronary stenting. Methods A total of 130 patients who underwent coronary stenting from June 2017 to June 2018 in our hospital were randomly selected. The patients were divided into two groups according to different medications. The control group received placebo adjuvant therapy on the basis of routine treatment. The study group added celecoxib treatment based on conventional treatment. Results The results of hsCRP examination in all groups were higher than those in the group before operation. The hsCRP of each group was increased 3 days after the operation was completed. The hsCRP of the study group was lower than that of the control 3 days after operation. The difference between the above groups was statistically significant (P<0.05). Conclusion The application of celecoxib in the treatment can effectively alleviate the increase of postoperative hsCRP ......